Balloon in the womb: could it save babies with underdeveloped lungs?

NCT ID NCT04583644

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a procedure called FETO in 10 unborn babies with severe left congenital diaphragmatic hernia (CDH). In CDH, a hole in the diaphragm allows organs to move into the chest, preventing normal lung growth. FETO involves placing a tiny balloon in the baby's windpipe via fetoscopy to block fluid outflow, stretching the lungs and encouraging growth. The balloon is removed later in pregnancy. The goal is to see if the procedure is feasible and safe enough to study further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Fetoscopic Endoluminal Tracheal Occlusion (FETO) surgery with a balloon device

What this could lead to

If successful, this procedure could help severely affected babies with CDH grow more lung tissue before birth, potentially improving their chances of survival after delivery.

What could go wrong

This is a very small pilot study (10 participants) focused on feasibility, not yet on proven outcomes. The procedure carries risks for both mother and fetus, including preterm labor or balloon complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL DIAPHRAGMATIC HERNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital diaphragmatic hernia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California San Francisco Fetal Treatment Center

    RECRUITING

    San Francisco, California, 94158, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••